品牌 | 货号 | 包装单位 | 货期 | CAS | 产品名称 | 质量规格 | 单价(¥) | 购买数量 |
---|---|---|---|---|---|---|---|---|
罗恩 | R027778-25mg | 25mg | 5~7个工作日 | 1415800-43-9 |
UNC1215 UNC1215 |
98% |
|
|
罗恩 | R027778-50mg | 50mg | 5~7个工作日 | 1415800-43-9 |
UNC1215 UNC1215 |
98% |
|
|
罗恩 | R027778-5mg | 5mg | 5~7个工作日 | 1415800-43-9 |
UNC1215 UNC1215 |
98% |
|
|
罗恩 | R027778-10mg | 10mg | 5~7个工作日 | 1415800-43-9 |
UNC1215 UNC1215 |
98% |
|
|
罗恩 | R027778-100mg | 100mg | 5~7个工作日 | 1415800-43-9 |
UNC1215 UNC1215 |
98% |
|
|
阿拉丁 | U125324-5mg | 5mg | 期货,请咨询 | 1415800-43-9 |
UNC1215,L3MBTL3 甲基赖氨酸结构域的拮抗剂 UNC1215 |
Moligand™, ≥98% |
|
|
阿拉丁 | U125324-10mg | 10mg | 现货 | 1415800-43-9 |
UNC1215,L3MBTL3 甲基赖氨酸结构域的拮抗剂 UNC1215 |
Moligand™, ≥98% |
|
|
阿拉丁 | U125324-25mg | 25mg | 现货 | 1415800-43-9 |
UNC1215,L3MBTL3 甲基赖氨酸结构域的拮抗剂 UNC1215 |
Moligand™, ≥98% |
|
|
阿拉丁 | U125324-50mg | 50mg | 现货 | 1415800-43-9 |
UNC1215,L3MBTL3 甲基赖氨酸结构域的拮抗剂 UNC1215 |
Moligand™, ≥98% |
|
|
阿拉丁 | U125324-100mg | 100mg | 现货 | 1415800-43-9 |
UNC1215,L3MBTL3 甲基赖氨酸结构域的拮抗剂 UNC1215 |
Moligand™, ≥98% |
|
|
阿拉丁 | U125324-250mg | 250mg | 现货 | 1415800-43-9 |
UNC1215,L3MBTL3 甲基赖氨酸结构域的拮抗剂 UNC1215 |
Moligand™, ≥98% |
|
|
阿拉丁 | U421537-1ml | 1ml | 现货 | 1415800-43-9 |
UNC1215 UNC1215 |
Moligand™, 10mM in DMSO |
|
|
毕得 | BD305591-50mg | 50mg | 现货 | 1415800-43-9 |
(2-(苯氨基)-1,4-亚苯基)双((4-(吡咯烷-1... (2-(Phenylamino)-1,4-phenyle... |
98+% |
|
|
毕得 | BD305591-100mg | 100mg | 现货 | 1415800-43-9 |
(2-(苯氨基)-1,4-亚苯基)双((4-(吡咯烷-1... (2-(Phenylamino)-1,4-phenyle... |
98+% |
|
|
毕得 | BD305591-250mg | 250mg | 现货 | 1415800-43-9 |
(2-(苯氨基)-1,4-亚苯基)双((4-(吡咯烷-1... (2-(Phenylamino)-1,4-phenyle... |
98+% |
|
|